Keep Us Human:
If We're Truly Smart, We'll Refuse to Foolishly Tamper with Our DNA
By Bill McKibben,
Los Angeles Times
| 04. 14. 2003
The 50th anniversary of the double helix has been greeted with
worldwide hoopla. It began in February, the month that James
Watson and Francis Crick actually made their discovery, and
will culminate this month with the golden anniversary of the
paper they published announcing the news to the world.
The celebration is appropriate; understanding of the gene is
rivaled only by understanding of the atom as the great scientific
achievement of the last century. But just as cracking the atom
raised the deepest ethical and practical dilemmas, so too does
cracking the gene. Our new knowledge of genetic manipulation
forces us to ask a question other generations couldn't have
imagined: Are we a good enough species?
Consider Watson, who has been the towering figure in genetics
research since that first paper -- the "commanding general"
of the DNA revolution, in the words of London's Guardian. He
has used his fame and influence to push for changing human beings
in the most radical ways. Human embryos should be manipulated,
he has said, to increase intelligence, to eliminate shyness,
even to make...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...